Decibine 50mg IV Inj. 1`s

A qualified oncology team administers it as an intravenous infusion in defined treatment cycles.

Decibine 50mg IV Injection Ingredients and Usage

Decibine 50mg IV Injection contains decitabine, a nucleoside metabolic inhibitor belonging to the hypomethylating agent drug class. Oncologists prescribe it for myelodysplastic syndromes, including refractory anemia and chronic myelomonocytic leukemia, across previously treated and untreated disease.

Decibine 50mg IV Injection is also used to treat acute myeloid leukemia. Dosing follows specific cycle schedules based on body surface area, and treatment is guided by a hematologist or oncologist experienced in these disorders.

How Does Decibine 50mg IV Injection Work?

Decitabine is incorporated into DNA during cell division, where it inhibits DNA methyltransferase, an enzyme responsible for adding methyl groups that silence certain genes. This process is known as hypomethylation.

By reversing abnormal gene silencing, Decibine 50mg IV Injection can restore normal function to genes that control cell differentiation and proliferation in myelodysplastic and leukemic cells. In rapidly dividing cells, decitabine also forms covalent bonds with DNA methyltransferase, contributing to direct cytotoxic effects on cancer cells.

Decibine 50mg IV Injection Side Effects

Decibine 50mg IV Injection commonly causes blood count changes and digestive side effects.

• Low white blood cell, red blood cell, and platelet counts

• Fatigue and weakness

• Nausea and vomiting

• Diarrhea or constipation

• Mouth sores

• Decreased appetite

• Hair thinning

Warnings

• Decibine 50mg IV Injection commonly causes myelosuppression; complete blood counts must be monitored regularly throughout treatment, and dose delays or adjustments may be needed.

• Neutropenia significantly increases infection risk; report fever, chills, or signs of infection to the treating doctor immediately.

• Decibine 50mg IV Injection can cause fetal harm and is not recommended during pregnancy; effective contraception is required for both men and women during treatment.

• Male patients should be advised of potential effects on fertility, since animal studies showed reduced sperm counts and testicular changes at relevant doses.

• As a cytotoxic agent, Decibine 50mg IV Injection must be handled and prepared with appropriate precautions by trained personnel.

• Use with caution in patients with pre-existing liver or kidney impairment, since safety in significant organ dysfunction has not been well established.

• Monitor closely for tumor lysis syndrome in patients with high disease burden at the start of treatment.

Decibine 50mg IV Injection Storage Conditions

Store Decibine 50mg IV Injection as an unreconstituted vial at room temperature, following the storage instructions on the vial label. Keep the vial in its original packaging until immediately before reconstitution. Store this medicine out of reach of children and ensure only trained healthcare staff handle preparation and administration.